section name header

Question ⬇

Reduction of Risk Potential

leftnavigator11 home rgtnavigator11

42. A client, who is 23 years old, gravida 2, para 0, had a miscarriage at 6 weeks' gestation last year. She presents for her first prenatal appointment at 12 weeks' gestation. She is having blood drawn for routine prenatal screening. Which laboratory result would indicate a risk to the fetus for erythroblastosis fetalis?

Choices

Choices ⬆ ⬇

1. Low α-fetoprotein.

2. Blood type B–, antibody +.

3. Lecithin/sphingomyelin ratio of 2:1.

4. Blood type O+, antibody –.

Question  Hint

Hints ⬆ ⬇

Test-Taking Tip

Remember: if a woman is Rh negative and antibody +, the fetus is at risk for developing Rh incompatibility and possibly erythroblastosis fetalis. Eliminate Answers 1 and 3 because they do not test for erythroblastosis fetalis.

Content Area: Maternity, Antepartum; Integrated Process: Nursing Process, Analysis; Cognitive Level: Application; Client Need/Subneed: Physiological Integrity/Reduction of Risk Potential/Laboratory Values

Go to Choices

Rationale ⬆

Reduction of Risk Potential

leftnavigator11 home rgtnavigator11

2.  

Answer 1 is incorrect because α-fetoprotein (AFP) is drawn in the second trimester around 18 weeks' gestation. Low AFP may indicate Down syndrome. Answer 2 is correct because this client has a positive (+) antibody screen indicating antibodies are present. The antibodies formed by a mother can cause erythroblastosis fetalis. Blood and Rh typing and antibody screening can alert the physician to the possible development of this condition. Answer 3 is incorrect because the lecithin/sphingomyelin ratio is obtained from amniotic fluid analysis and indicates fetal lung maturity. This test is not performed in the first trimester of pregnancy. Answer 4 is incorrect because the antibody screen is negative, indicating that the client has not developed antibodies that can cause erythroblastosis fetalis.

Go to Question